Aerovate Therapeutics Inc
NASDAQ:AVTE

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:AVTE
Watchlist
Price: 2.66 USD 1.92% Market Closed
Market Cap: 76.8m USD
Have any thoughts about
Aerovate Therapeutics Inc?
Write Note

Wall Street
Price Targets

AVTE Price Targets Summary
Aerovate Therapeutics Inc

Wall Street analysts forecast AVTE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVTE is 2.38 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.

Lowest
Price Target
2.02 USD
24% Downside
Average
Price Target
2.38 USD
11% Downside
Highest
Price Target
3.15 USD
18% Upside

AVTE Last Price Targets
Aerovate Therapeutics Inc

The latest public price target was made on Jun 17, 2024 by Liisa Bayko from Evercore ISI , who expects AVTE stock to drop by 25% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Liisa Bayko
Evercore ISI
2 USD
Downside 25%
5 months ago
Jun 17, 2024
Aerovate Therapeutics downgraded to In Line from Outperform at Evercore ISI
TheFly
Eun Yang
Jefferies
2 USD
Downside 25%
5 months ago
Jun 17, 2024
Jefferies Downgrades Aerovate Therapeutics Inc (AVTE) to Hold
StreetInsider
Tiago Fauth
Wells Fargo
35 USD
Upside 1 216%
7 months ago
Apr 1, 2024
Wells Fargo Adds Aerovate Therapeutics Inc (AVTE) to Q2 '24 Tactical Ideas List
StreetInsider
Eun Yang
Jefferies
65 USD
Upside 2 344%
7 months ago
Mar 25, 2024
Aerovate Therapeutics Inc (AVTE) PT Raised to $65 at Jefferies, 'valuation does not suggest data needs to be better than sotatercept'
StreetInsider
Liisa Bayko
Evercore ISI
Price Target 2 USD
Upside/Downside 25%
View Source
Eun Yang
Jefferies
Price Target 2 USD
Upside/Downside 25%
View Source
Tiago Fauth
Wells Fargo
Price Target 35 USD
Upside/Downside 1 216%
View Source
Eun Yang
Jefferies
Price Target 65 USD
Upside/Downside 2 344%
View Source
Aerovate Therapeutics Inc Competitors:
Price Targets
0HS8
Caladrius Biosciences Inc
419% Upside
ANAB
AnaptysBio Inc
156% Upside
LTRN
Lantern Pharma Inc.
633% Upside
ARWR
Arrowhead Pharmaceuticals Inc
160% Upside
IFRX
InflaRx NV
308% Upside
SPRO
Spero Therapeutics Inc
343% Upside
RXRX
Recursion Pharmaceuticals Inc
76% Upside
FLUO
Fluoguide AS
309% Upside

Revenue
Forecast

Revenue Estimate
Aerovate Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aerovate Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Aerovate Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVTE's stock price target?
Price Target
2.38 USD

According to Wall Street analysts, the average 1-year price target for AVTE is 2.38 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.

Back to Top